This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The National Institutes of Health is at a crossroads with the RECOVER Initiative, its flagship program to address long Covid. Designed to provide answers and treatments for the millions suffering from long-term effects of SARS-CoV-2 infection, the initiative has already received significant criticism for failing to prioritize the needs of patients and advance meaningful clinical trials.
Michael Reilly in RealClearHealth: Don’t Let a “Lame Duck” Congress Gamble with Patient Health On December 20th, RealClearHealth published an op-ed by ASBM Executive Director Michael Reilly discussing concerns that the Biosimilar Red Tape Elimination Act would lower standards for biosimilar medications. The opinion highlights concerns that this bill might be included in the end of year continuing resolution bill, without properly considering the impacts on patients.
The National Cancer Institute (NCI) has had a taxpayer-funded drug development program for nearly 70 years, initiated at a time when there was no private investment in oncology drugs. I worked closely with NCI’s Investigational Drug Branch (IDB) from 1990-2016, including as a principal investigator of one of only six contracts with NCI to conduct Phase 1 clinical trials from 1990-1995, and serving as co-chair of NCI’s Investigational Drug Steering Committee from 2005-2008.
Prescribers must independently verify a persons weight, height and/or body mass index before prescribing weight-loss medication, new guidance from the General Pharmaceutical Council (GPhC) has mandated. And for all high-risk medicines, prescribing decisions cannot solely be based on information provided through an online questionnaire. Any information provided by a patient must be independently verified, either […] The post New rules for online pharmacies supplying weight-loss injections a
Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.
Alembic Pharmaceuticals has announced that Dr Archana Hingorani has completed her second consecutive term of five years as an Independent Director of the company. Following the completion of her tenure, she ceases to be a Director with effect from the end of the day on 3 February 2025. The company disclosed this development in a regulatory filing under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Y ou’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get it delivered in your inbox every Tuesday and Thursday. Good morning health tech readers!
Eli Lilly and Company (Lilly) has announced the appointment of Winselow Tucker as President and General Manager for Lilly India, effective immediately. He will oversee all of Lillys operations in India, including the Lilly India commercial organisation and the Lilly Capability Centre India (LCCI) in Bengaluru and Hyderabad. As part of this transition, Vineet Gupta, Associate Vice President and Managing Director, India, will move to a new leadership role at Lillys headquarters in Indianapolis, US
89
89
Signup to get articles personalized to your interests!
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
Eli Lilly and Company (Lilly) has announced the appointment of Winselow Tucker as President and General Manager for Lilly India, effective immediately. He will oversee all of Lillys operations in India, including the Lilly India commercial organisation and the Lilly Capability Centre India (LCCI) in Bengaluru and Hyderabad. As part of this transition, Vineet Gupta, Associate Vice President and Managing Director, India, will move to a new leadership role at Lillys headquarters in Indianapolis, US
The pharmaceutical industry is in a period of rapid transformation. Driven by innovation and evolving patient needs, companies face challenges balancing competitiveness, regulatory hurdles, R&D improvements, and diversity initiatives. Three key trends define this era: 1. Diversity in Clinical Trials: A Core Priority Diversity in trials is shifting from compliance to a core design element.
The Pharmaceuticals Export Promotion Council of India (Pharmexcil), an authorised body under the Government of India for pharmaceutical export promotion, has appointed Bhavin Mukund Mehta, Wholetime Director of Kilitch Drugs (India) Limited, as its Vice-Chairman. Bhavin Mehta has over 25 years of experience in the pharmaceutical industry. As Director at Kilitch Drugs (India), he led the companys export initiatives, expanding its presence beyond India while also strengthening its position in the
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
ICYMI, the largest three pharmaceutical wholesalersCardinal Health, Cencora, and McKessonare using vertical integration to build significant market positions in businesses beyond drug distribution. In the video clip below, I review the vertical integration status of the largest three pharmaceutical wholesalers, illustrated in the chart below. [Click to Enlarge] I also: Explain how wholesalers have strengthened their position in buy-and-bill channels for provider-administered drugs through vertic
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
Revolutionise your research process with Axtria Rapid CSR to produce faster and more accurate clinical study reports. Improve efficiency and accuracy in your clinical studies with these advanced solutions.
Sen. Bill Cassidy, whose “yes” vote advanced Kennedy’s nomination as health secretary, said Kennedy promised to maintain a key CDC vaccine panel without change.
Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.
Group action with 3,500 claimants alleges company knew its talcum powder products contained dangerous asbestos Lawyers representing 3,500 claimants are preparing to sue the pharmaceutical firm Johnson & Johnson (J&J) over alleged links between talcum powder and cancer, in what is expected to be one of the largest pharmaceutical product group actions in English and Welsh legal history.
Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.
Secondary prevention medications for cardiovascular diseases (CVD) are underused globally and additional strategies to increase their use are needed to improve CVD management and reduce premature mortality rates, according to study published today in JACC, the flagship journal of the American College of Cardiology. The study observed participants with CVD from 17 countries over 12 years and found that medication use remains low with little improvement.
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content